9 employees
Adapsyn is developing a bioinformatics platform devoted to discovering previously unidentified natural product drug candidates.
2016
Adapsyn Bioscience raised undisclosed on October 18, 2022
Investors: Bill & Melinda Gates Foundation
Adapsyn Bioscience raised undisclosed on January 11, 2018
Investors: Genesys Capital